ArticleBMJ open2026
The return to work after arthroplasty (REWARD) cohort: a nationwide longitudinal study of sick leave and disability pension among individuals receiving hip and knee arthroplasty in Sweden.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe return to work after arthroplasty (REWARD) study was established to address knowledge gaps regarding factors influencing return to work and long-term workability following hip and knee arthroplasty. The study investigates how variables such as sex, occupational workload and prior treatments affect sick leave patterns across regions and healthcare providers in Sweden. By analysing trajectories of sick leave and disability pension before and after surgery, the study aims to identify determinants for successful return to work.
participantsInitially, we identified two separate cohorts comprising all individuals registered in the Swedish Arthroplasty Register who received a primary hip or knee arthroplasty between 2012 and 2022. Eligible individuals were 18-69 years of age and had osteoarthritis (OA) as the indication for surgery. For each of the arthroplasty cohorts, Statistics Sweden created a reference cohort by randomly selecting three individuals from the general population for each arthroplasty case, matched on age, sex and municipality. FINDINGS TO DATE: Using linked nationwide registers, we identified 64 370 individuals who received primary hip arthroplasty and 60 683 who received knee arthroplasty during 2012-2022, all aged 18-69 years and diagnosed with OA. Median age was 62 years (IQR 56-66) for hip and 63 years (IQR 58-66) for knee arthroplasty; 52% and 55% were women respectively.The corresponding matched cohorts consisted of 193 110 and 182 049 individuals respectively.The dataset includes patient and surgical characteristics, 1-year patient-reported outcomes, first-line treatment participation, socioeconomic data, occupational exposures and sick leave and disability pension data (5 years before and after surgery). Data collection is complete. FUTURE PLANS: The REWARD cohort is intended for longitudinal analysis of return to work and long-term workability following hip and knee arthroplasty, and for quantifying associated societal costs. Data collection is anticipated to be completed in 2027, pending potential linkage of comorbidity and prescribed medication data. Findings from REWARD will inform national guidelines and decision support tools for sick leave and work-related rehabilitation. Future work includes co-developing individualised, work-oriented interventions in collaboration with patients and healthcare professionals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.